Literature DB >> 12898245

Periacinar retraction clefting in the prostatic needle core biopsies: an important diagnostic criterion or a simple artifact?

Bozo Kruslin1, Davor Tomas, Hermann Rogatsch, Irena Novosel, Hrvoje Cupić, Mladen Belicza, Ognjen Kraus, Gregor Mikuz.   

Abstract

The diagnosis of prostatic adenocarcinoma in needle core biopsy is based on major and supportive criteria. One of the supportive criteria is the presence of retraction clefting around neoplastic glands. We analyzed a series of 137 prostatic cancer cases diagnosed by needle core biopsy to determine the frequency, extent and criteria for periacinar retraction clefting. Clefting was analyzed on ten neoplastic and ten normal glands in three different high power fields. One-third or more glands with clefts affecting more than 50% of circumference were significantly more common in tumors (51.8%) than in benign glands (8%) (P<0.0001). A stricter criterion that designated as positive the cases with at least 50% of neoplastic glands (15 of 30) with clefts that affected more than 50% of circumference revealed clefts in only 15.3% of the malignant cases but none in benign cases (0%) (P<0.0001). Regardless of their extension, 15 or more glands with clefts were also more prominent in malignant cases (86.9%) than in benign cases (20.4%) (P<0.0001). We conclude that periacinar retraction clefting represents a reliable criterion for diagnosis of the prostatic adenocarcinoma, especially in cases with clefts affecting more than 50% of circumference in at least 50% of suspicious glands.

Entities:  

Mesh:

Year:  2003        PMID: 12898245     DOI: 10.1007/s00428-003-0862-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  7 in total

1.  Perineural invasion, mucinous fibroplasia, and glomerulations: diagnostic features of limited cancer on prostate needle biopsy.

Authors:  B L Baisden; H Kahane; J I Epstein
Journal:  Am J Surg Pathol       Date:  1999-08       Impact factor: 6.394

2.  Optimized preembedding method improves the histologic yield of prostatic core needle biopsies.

Authors:  H Rogatsch; T Mairinger; W Horninger; A Gschwendtner; G Bartsch; G Mikuz
Journal:  Prostate       Date:  2000-02-01       Impact factor: 4.104

3.  Carcinoma of the prostate in patients 70 to 79 years old.

Authors:  B Halpert; W R Schmalhorst
Journal:  Cancer       Date:  1966-05       Impact factor: 6.860

4.  Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens. A study of 250 consecutive cases in a routine surgical pathology practice.

Authors:  Murali Varma; Min W Lee; Pheroze Tamboli; Richard J Zarbo; Rafael E Jimenez; Paulo G O Salles; Mahul B Amin
Journal:  Arch Pathol Lab Med       Date:  2002-05       Impact factor: 5.534

5.  Diagnostic effect of an improved preembedding method of prostate needle biopsy specimens.

Authors:  H Rogatsch; P Moser; H Volgger; W Horninger; G Bartsch; G Mikuz; T Mairinger
Journal:  Hum Pathol       Date:  2000-09       Impact factor: 3.466

6.  Minimal carcinoma in prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up.

Authors:  P Thorson; R T Vollmer; C Arcangeli; D W Keetch; P A Humphrey
Journal:  Mod Pathol       Date:  1998-06       Impact factor: 7.842

7.  Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy.

Authors:  J I Epstein
Journal:  Hum Pathol       Date:  1995-02       Impact factor: 3.466

  7 in total
  8 in total

1.  Peritumoral Clefting and Expression of MMP-2 and MMP-9 in Basal Cell Carcinoma of the Skin.

Authors:  Ivana Manola; Ana Mataic; Daniela Ledic Drvar; Ivan Pezelj; Tihana Regovic Dzombeta; Bozo Kruslin
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting.

Authors:  Tihana Džombeta; Božo Krušlin
Journal:  Pathol Oncol Res       Date:  2017-07-27       Impact factor: 3.201

3.  Periacinar retraction clefting in nonneoplastic and neoplastic prostatic glands: artifact or molecular involvement.

Authors:  Wagner José Fávaro; Amanda Cia Hetzl; Leonardo Oliveira Reis; Ubirajara Ferreira; Athanase Billis; Valéria Helena A Cagnon
Journal:  Pathol Oncol Res       Date:  2011-09-13       Impact factor: 3.201

4.  Periacinar retraction clefting and d2-40 expression in prostatic adenocarcinoma.

Authors:  Monika Ulamec; Tihana Džombeta; Hrvoje Cupić; Tanja Leniček; Davor Tomas; Božo Krušlin
Journal:  Pathol Oncol Res       Date:  2011-09-13       Impact factor: 3.201

5.  Periacinar Clefting and p63 Immunostaining in Prostatic Intraepithelial Neoplasia and Prostatic Carcinoma.

Authors:  Bozo Kruslin; Davor Tomas; Aida Cviko; Hrvoje Cupic; Ljubica Odak; Mladen Belicza
Journal:  Pathol Oncol Res       Date:  2006-12-25       Impact factor: 3.201

6.  Periacinar retraction clefting in proliferative prostatic atrophy and prostatic adenocarcinoma.

Authors:  Monika Ulamec; Davor Tomas; Christian Ensinger; Hrvoje Cupic; Mladen Belicza; Gregor Mikuz; Bozo Kruslin
Journal:  J Clin Pathol       Date:  2007-02-13       Impact factor: 3.411

7.  Peritumoral retraction clefting correlates with advanced stage squamous cell carcinoma of the esophagus.

Authors:  Tatjana Bujas; Ivana Pavić; Tanja Lenicek; August Mijić; Bozo Kruslin; Davor Tomas
Journal:  Pathol Oncol Res       Date:  2008-04-16       Impact factor: 3.201

Review 8.  Prostate cancer stroma: an important factor in cancer growth and progression.

Authors:  Božo Krušlin; Monika Ulamec; Davor Tomas
Journal:  Bosn J Basic Med Sci       Date:  2015-05-13       Impact factor: 3.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.